US Patent 11485732 Compounds and uses thereof
Patent 11485732 was granted and assigned to Foghorn Therapeutics on November, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 29, 2021
Date of Patent
November 1, 2022
Patent Applicant
Patent Application Number
17162103
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11485732 Compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.